Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Irinotecan in Advanced Colorectal Cancer
NCT00336856Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Jun 2006
- Primary completion
- Jun 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in colorectal cancer (CRC), sponsored by University of Pittsburgh. Started Jun 2006; status: completed.
02
Drugs
KL-140
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00336856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336856.